J.P. Morgan 35 th Annual Healthcare Conference. DRAFT 01/04/17 1p

Size: px
Start display at page:

Download "J.P. Morgan 35 th Annual Healthcare Conference. DRAFT 01/04/17 1p"

Transcription

1 J.P. Morgan 35 th Annual Healthcare Conference DRAFT 01/04/17 1p

2 Forward-Looking Statements This presentation includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (the Securities Act ), and Section 21E of the Securities Exchange Act of 1934, as amended (the Exchange Act ). These forward-looking statements include, but are not limited to, all statements regarding the ability of Kindred Healthcare, Inc. ( Kindred or the Company ) to exit the skilled nursing facility business and the expected timing of such exit, as well as the Company s ability to realize the anticipated benefits, sale proceeds, cost savings and strategic gains from this initiative, all statements regarding the Company s expected future financial position, results of operations, cash flows, dividends, financing plans, business strategy, budgets, capital expenditures, competitive positions, growth opportunities, plans and objectives of management, government investigations, regulatory matters and statements containing the words such as anticipate, approximate, believe, plan, estimate, expect, project, could, would, should, will, intend, may, potential, upside, and other similar expressions. Statements in this presentation concerning the Company s business outlook or future economic performance, anticipated profitability, revenues, expenses, dividends or other financial items, product or services line growth, and expected outcomes of government investigations and other regulatory matters, together with other statements that are not historical facts, are forward-looking statements that are estimates reflecting the best judgment of the Company based upon currently available information. Such forward-looking statements are inherently uncertain, and stockholders and other potential investors must recognize that actual results may differ materially from the Company s expectations as a result of a variety of factors. Such forward-looking statements are based upon management s current expectations and include known and unknown risks, uncertainties and other factors, many of which the Company is unable to predict or control, that may cause the Company s actual results, performance or plans to differ materially from any future results, performance or plans expressed or implied by such forward-looking statements. These statements involve risks, uncertainties and other factors detailed from time to time in the Company s Annual Report on Form 10-K, Quarterly Reports on Form 10-Q and Current Reports on Form 8-K filed with the Securities and Exchange Commission that may affect the Company s plans, results or stock price. Many of these factors are beyond the Company s control. The Company cautions investors that any forward-looking statements made by the Company are not guarantees of future performance. The Company disclaims any obligation to update any such factors or to announce publicly the results of any revisions to any of the forward-looking statements to reflect future events or developments, except as may be required by law. Kindred has provided in this presentation certain non-generally accepted accounting principles ( GAAP ) measures for specified periods. A reconciliation of the non-gaap measures to the comparable GAAP measures is included in this presentation. 2

3 Kindred is one of the Leading Providers of Rehabilitation and Post-Acute Care in the U.S. Kindred is 102,200 dedicated teammates taking care of approximately 1,040,000 patients and residents in more than 2,700 locations in 46 states Our Mission Kindred s mission is to promote healing, provide hope, preserve dignity and produce value for each patient, resident, family member, customer, employee and shareholder we serve. Our Management Philosophy Kindred s management philosophy is to focus on our people, on quality and customer service and our business results will follow. As of October 1,

4 The Kindred Investment Thesis An aging population is significantly increasing the demand for postacute services The need for higher value post-acute care is becoming increasingly recognized regardless of the pace of evolution toward valuebased payment models Kindred has unparalleled post-acute expertise across the continuum, with national scale, scope, and high quality outcomes Kindred s technology and analytics-enabled care capabilities are in demand by hospital systems and payors Kindred s flexible JV model is a key growth driver and unique in its breadth Kindred s repositioning will enhance future performance, with a focus on higher-growth, less capital-intensive businesses to drive earnings and cash flow growth 4

5 An Aging Population is Significantly Increasing Demand for Post-Acute Services Number of Americans 65 or Older There are 54 (1) million Medicare beneficiaries and 11,000 (2) are added to the program each day million The number of people 85 and older is expected to triple by % (3) (nearly 7 million) will require post-acute care million More than 16 million Medicare Fee-For-Service Patients are discharged annually from Acute Care Hospitals Kindred is there for them. Source: U.S. Census Bureau, 2008 (1) Kaiser Family Foundation: Medicare at a Glance, September (2) HHS Secretary Sebelius: Senior Health Town Hall, June 11, (3) Mark Miller, MedPAC Executive Director: Congressional Testimony, June

6 Post-Acute Care is Vital to Improving Quality and Reducing Costs Nearly half of Medicare patients leaving acute care require post-acute care 10% of Medicare beneficiaries account for nearly 60% of spending (1) solutions to create savings and improved health are vital But today, most post-acute care is not well managed, with high readmissions and lack of care coordination from the hospital to home Institute of Medicine has shown that 73% of the variation in Medicare spending from market to market is attributable to post-acute care As a result, hospital systems and payors are demanding a post-acute care solution (1) Kaiser Family Foundation analysis of the CMS Medicare Current Beneficiary Survey Cost and Use File,

7 Kindred Has Built a Market-Leading Platform to Thrive in a Rapidly Changing Environment #1 Operator of Home Health and Hospice (1) #1 Operator of Transitional Care Hospitals (1) #1 Operator of Rehabilitation Services (1) $2.5 billion Revenues (2) $2.4 billion Revenues (2) $1.5 billion Revenues (2) 647 sites of service 395 home health, 185 hospice and 67 community care in 40 states (4) 40,368 caregivers serving 130,000 patients daily (4) Kindred House Calls home-based primary care 100 Practitioners in 12 markets (5) 82 Transitional Care Hospitals (3) 6,107 licensed beds (3) 12 Hospital-Based Sub-Acute Units (3) 19 Inpatient Rehabilitation Hospitals with 969 licensed beds (4) 104 hospital-based inpatient rehabilitation units (4) 1,740 sites of service served through 18,376 therapists (4) and Kindred outperforms national benchmarks on key quality indicators (6) 91% of home health locations rated 3 stars or higher in CMS s 5-Star rating system Low readmission rates, high ventilator weaning rates IRFs and ARUs outperformed peers in Functional Improvement Measures (FIM) (1) Ranking based on 2015 revenues. (2) Revenues for the twelve months ended September 30, 2016 (divisional revenues before intercompany eliminations). (3) As of October 1, (4) As of September 30, (5) As of December 31, (6) Kindred Quality Report. 7

8 National Scale and Presence in Local Integrated Care Markets Positions Kindred to Meet the Growing Demand for Post-Acute Care Kindred s 23 current Integrated Care Markets are among the top 30 MSAs in the U.S. National presence across 46 states Significant patient opportunity for improved care transitions and choice provides revenue synergies from referrals across the combined care delivery platform Transitional Care Hospitals (82) Inpatient Rehabilitation Hospitals (19) Kindred at Home Sites of Service (647) Hospital-Based Inpatient Rehabilitation Units (104) RehabCare External Customers (1,740) National and Regional Support Centers Integrated Care Markets (23) PR As of October 1,

9 Kindred has Significantly Diversified its Business Offerings and Transformed its Business Mix Revenues (1) YESTERDAY (2010 (2) ) TODAY (3), adjusted to exclude Nursing Center Division (LTM 3Q16) Kindred at Home Hospitals 47% 42% 39% 38% Rehab Nursing Centers 11% Kindred at Home 0% 23% Total: $4.7 billion Total: $6.4 billion Adjusted EBITDA (4) Divisional Mix YESTERDAY (2010 (2) ) 19% TODAY (5), adjusted to exclude Nursing Center Division (LTM 3Q16) 29% Kindred at Home Hospitals Rehab Nursing Centers 14% 67% Kindred at Home 0% 45% 26% Total: $225 million Total: $587 million (1) Revenues before intercompany eliminations for each respective period. See Appendix for reconciliation. (2) Revenues and Adjusted EBITDA (defined below) have not been restated for operations discontinued in the 2013/2014 restructuring. See the Appendix for a summary of amounts as originally reported in the Form 10-K. (3) Includes Kindred revenues for the twelve months ended September 30, (4) Adjusted earnings before interest, income taxes, depreciation and amortization ( Adjusted EBITDA ) is defined as core EBITDA (as calculated as set forth in the Appendix) after allocating support center overhead based upon percentage of total revenues by division (before intercompany eliminations) for each respective period. See Appendix for reconciliation. (5) Includes Kindred Adjusted EBITDA for the twelve months ended September 30, 2016, after allocating support center overhead based upon percentage of total revenues by division (before intercompany eliminations). 9

10 The Kindred Solution 10

11 Kindred is Positioned to Provide Hospital Systems and Payors the Post-Acute Solution They are Demanding Hospital systems and payors want a solution that: Maintains line of sight on patients when they leave hospitals Has a reliable and high-performing postacute care network to improve core performance, care transitions and reduce readmissions Has objective site placement and care management solutions Prepares for the ongoing evolution to valuebased payments Kindred is uniquely positioned for a value-based world 11

12 Kindred is Developing High-Performance PAC Networks Through Partnerships with Health Systems Create Joint Ventures of PAC assets with Health Systems Convene & manage networks across the post-acute care continuum Kindred Health System Partner JV owned PAC assets Patient discharge (acute care) Kindred/JV PAC assets Kindred at Home Affiliated PAC providers Deploy differentiated Patient Placement and Care Management capabilities enabled by IT and analytics 12

13 Kindred is Developing Differentiated Capabilities to Enable High-Performance Networks Care Management Network Management Evidence-based site placement, with technology-enabled tool Centralized Contact Center that enables telephonic care management Innovative product development team Network creation and management infrastructure and processes Data integration and reporting across network facilities Kindred s Contact Center will enable comprehensive care management capabilities to support multiple post-acute networks 13

14 Kindred s Care Management Capabilities Over a Patient s Journey Patient admission Acute care stay (Health system partner) Discharge to post-acute facility Post-acute care stay (Network facility) Discharge to home Kindred (performed by Kindred Contact Center) Risk stratification and patient placement recommendation Discharge Planning (performed by Kindred Contact Center) Onsite Care Management supports care transition Onsite Care Management supports care transition Telephonic guidance Driven by evidence Facility selection Facilitates workflows and documentation Manage transition home Telephonic support to discharged patients 14

15 Kindred Has Joint Venture Experience with Health Systems Across the Country (1) (1) Included: Transitional Care Hospitals IRF Home Health Hospice Care Management (1) The Craig and Shepherd relationships are affiliations. 15

16 Strengthening the Core 16

17 Kindred Has Taken Decisive Action to Successfully Execute its Strategy Acquired Gentiva to enable home-based care Divestiture of nursing centers Optimized LTAC portfolio and executing plan to mitigate LTAC criteria Significantly reducing overhead Focus on Higher-Growth, Less Capital-Intensive Businesses 17

18 Strategic and Financial Value of Nursing Center Divestiture Strategic Value Financial Value (1) Focuses resources on higher-growth, higher-margin and less capitalintensive businesses Exit allows Kindred to build a robust virtual portfolio of SNFs through preferred provider relationships with best-in-class SNF operators in each market Gives our integrated care markets significantly better coverage to support network strategy Expected to be accretive to earnings and cash flow; deleveraging Expected to reduce rent by $90 million/year and capex by $30 million/year After-tax net proceeds from the sale of these assets is expected to range from $100 million to $300 million after transaction costs, severance expenses, and amount payable to Ventas SNF divestiture part of broader company effort to optimize overhead (part of $70 million to $100 million planned reduction) (1) These are forward-looking statements within the meaning of Section 27A of the Securities Act and Section 21E of the Exchange Act. See Forward-Looking Statements on page 2. 18

19 Multi-Faceted Strategy to Mitigate LTAC Criteria Post-Intensive Care Patient Strategy (Paid at LTAC Rate) Complex Medical Patient Strategy (Paid at Site-Neutral Rate) Portfolio Repositioning Strategy Hospital and market-specific plans developed and being executed to admit and treat eligible LTAC patients Abundance of eligible LTAC patients not currently using LTACs with no occupancy constraints Acute Care Hospital benefits = enhanced LTAC referrals Lower acuity and length of stay support alternative care models 25-day length of stay requirement does not apply Acceptance of complex medical patients paid at the site-neutral rate is important to referring physicians and hospitals Covering direct care costs supports incremental margin for Kindred Managed Care value opportunity LTAC closures (three in 2016) and divestitures (swap with Select, sale of 12 LTACs to Curahealth) Conversion to other facility types (e.g., managed care hospital) Co-location with other bed types Addition of ancillary outpatient services 19

20 Positive Early Results of LTAC Criteria Mitigation Repositioning strategy reduced LTAC bed capacity by 14% or 960 beds Same-hospital admissions growth of 1%, 3Q 2016 vs 3Q 2015 Favorable mix and length of stay reduction have yielded an overall increase in revenue per patient day 86% of hospital revenues from all payor sources came from postintensive care patients paid at the LTAC rate for the first full month of criteria (September 2016) 3Q 2016 same-hospital revenues were equivalent year-over-year, post-criteria Multi-Faceted LTAC Mitigation Strategy Has Been Tailored to Specific Hospitals and Market Conditions 20

21 Summary

22 Kindred has Significantly Diversified its Business Offerings and Transformed its Business Mix $10.0 $9.0 $8.0 $7.0 $6.0 $5.0 $4.0 $3.0 Core EBITDA Margin (1) Revenue ($ billions) 8.9% 8.1% 7.2% 7.4% 5.2% $7.3 $6.2 $6.2 $5.0 $4.4 (2) (2) LTM 9/30/16 LTM 9/30/16 (3) (Excluding Nursing Center Division) 10.0% 9.0% 8.0% 7.0% 6.0% 5.0% 4.0% 3.0% Revenues (4) YESTERDAY (2010 (2) ) TODAY (3), adjusted to exclude Nursing Center Division (LTM 3Q16) Kindred at Home Hospitals 47% 42% 39% 38% Rehab Nursing Centers 11% Kindred at Home 0% 23% (1) Represents core earnings before interest, income taxes, depreciation and amortization ( EBITDA ) margin as reconciled in the Appendix. (2) Revenues have not been restated for operations discontinued in the 2013/2014 restructuring. See the Appendix for a summary of amounts as originally reported in the Form 10-K. (3) Includes Kindred revenues for the twelve months ended September 30, (4) Revenues before intercompany eliminations for each respective period. See Appendix for reconciliation. 22

23 Kindred s Multiple Growth Platforms: Home Health and Hospice Number One Operator of Home Health in U.S. HHHHH $1.7 billion in revenues (LTM 3Q 2016) 395 sites of service in 38 states (1) Number Two Operator of Hospice in U.S. Number two operator of Hospice in U.S. $729 million in revenues (LTM 3Q 2016) 185 sites of service in 31 states (1) 8.5% 7.5% 6.5% 5.5% 4.5% Projected Growth of Medicare Home Health Spend (2) Projected Growth of Hospice Industry (3) 8.5% 7.5% 6.5% 5.5% 4.5% 3.5% Same-store episode growth, 3Q 2016 vs. 3Q 2015: 6.9% 3.5% Same-store admission growth, 3Q 2016 vs. 3Q 2015: 8.3% (1) As of September 30, (2) National Health Expenditures: as published by the Office of the Actuary of the Centers for Medicare & Medicaid Services. (3) 2016 annual report of the boards of trustees of the Federal Hospital Insurance and Federal Supplementary Medical Insurance Trust Funds. 23

24 Kindred s Multiple Growth Platforms: IRFs Freestanding IRF Growth (1) $ Kindred has one of the largest Inpatient Rehab Platforms in the country and is poised to continue growing with a robust pipeline of de novo JV IRFs $330 $ $280 $230 $180 $130 $80 $ $188 $ $ LTM 9/30/ LTM 3Q 2016 Revenues $478 million - IRF $349 million - ARU (2) $129 million Locations 123 (3) Revenue ($millions) IRF Locations Same-store discharge growth, 3Q 2016 vs. 3Q 2015: 5.9% (1) Revenue includes Kindred IRFs plus Centerre s (historical preacquisition) revenues for the consolidated entities for each respective period. See Appendix for a reconciliation. (2) An acute rehabilitation unit ( ARU ) is certified as an IRF as it provides acute rehabilitation in a hospital-based setting. (3) As of September 30,

25 Key Takeaways Demographic trends and the need for higher-value post-acute care aligns with Kindred s strategy Aggressive actions taken by Kindred to reposition assets and develop care management and network management capabilities further enhances Kindred s ability to take advantage of these trends Multiple growth platforms in core service lines and through strategic partnerships position Kindred for success Kindred is Well-Positioned to Become a Unique Post-Acute Benefits Management Company 25

26 Q & A 26

27 DRAFT 01/04/17 1p J.P. Morgan 35 th Annual Healthcare Conference Appendix

28 Explanation of Kindred Non-GAAP Measures In addition to the results provided in accordance with United States GAAP, the Company has provided information in this presentation to compute certain non-gaap measures. The use of these non-gaap measures is not intended to replace the presentation of the Company s financial results in accordance with GAAP. Reconciliations of the non-gaap measures to the most directly comparable GAAP measures are included in the following pages of this presentation. EBITDA: The Company defines EBITDA as earnings before interest, income taxes, depreciation, and amortization, and believes that the presentation of EBITDA is useful to the investors because creditors, securities analysts and investors use EBITDA as a measure of earnings used to compare the performance of companies in the healthcare industry before consideration of the capital structure of fixed assets and financing costs, which can vary significantly among companies. For each of the Company s segments, EBITDA is a measure of performance used by the Company s chief operating decision makers in accordance with Accounting Standard Codification 280 Segment Reporting. In this context, the Company defines segment EBITDA as earnings before interest, income taxes, depreciation, and amortization, excluding litigation contingency expense, impairment charges, restructuring charges, transaction costs, and the allocation of support center overhead. Core EBITDA: The Company calculates core EBITDA by excluding from the most comparable GAAP measure (income (loss) from continuing operations) those charges related to transaction, integration, severance, retirement, retention, impairments, business interruption settlements, research and development, restructuring, debt amendment costs, facility/branch closings, and litigation. Adjusted EBITDA: The Company defines Adjusted EBITDA as core EBITDA after allocating the Company s support center overhead among its operating divisions based upon percentage of total revenues by division (before intercompany eliminations), thereby providing a more meaningful measure of segment performance. The Company s management uses core EBITDA and Adjusted EBITDA as meaningful measures of operational performance, in addition to other measures. In addition, the Company believes these measures are important, because securities analysts and investors use these measures to compare the Company s performance to other companies in the healthcare industry. For both core EBITDA and Adjusted EBITDA, the Company believes that income (loss) from continuing operations is the most comparable GAAP measure. Readers of the Company s financial information should consider income (loss) from continuing operations as an important measure of the Company s financial performance, because it provides the most complete measures of its performance. Operating results presented on a core or adjusted basis should be considered in addition to, not as a substitute for, or superior to, financial measures based upon GAAP as an indicator of operating performance. 28

29 Reconciliation of Non-GAAP Measures ($ in thousands) Twelve Year ended 2016 Quarters months ended Revenues by segment: 12/31/2010 (a) Q Q1 Q2 Q3 9/30/2016 Hospital division $ 1,973,321 $ 593,593 $ 643,299 $ 633,695 $ 575,323 $ 2,445,910 Kindred at Home: Home health - 425, , , ,958 1,744,308 Hospice - 178, , , , , , , , ,533 2,473,275 Kindred Rehabilitation Services 504, , , , ,498 1,459,571 Nursing center division 2,187, , , , ,259 1,088,268 Total revenues before intercompany eliminations 4,666,161 1,833,225 1,892,009 1,896,177 1,845,613 7,467,024 Intercompany eliminations (306,464) (52,276) (54,038) (54,107) (52,086) (212,507) Total revenues $ 4,359,697 $ 1,780,949 $ 1,837,971 $ 1,842,070 $ 1,793,527 $ 7,254,517 (a) Amounts as originally reported on the Company's Form 10-K. 29

30 Reconciliation of Non-GAAP Measures (continued) ($ in thousands) Nine Twelve Year ended December 31, months ended months ended Q /30/2016 9/30/2016 Revenues $4,359,697 $6,181,291 $5,027,599 $1,780,949 $5,473,568 $7,254,517 Income (loss) from continuing operations: Operating income (EBITDAR) 574, , , , , ,810 Rent 357, , ,039 97, , ,211 EBITDA 217, , , ,030 (5,431) 94,599 Depreciation and amortization 121, , ,570 40, , ,682 Interest, net 5, , ,767 55, , ,520 Income (loss) from continuing operations before income taxes 89,854 6,741 5,358 4,004 (299,607) (295,603) Provision (benefit) for income taxes 33,708 39, (51,980) 311, ,490 Income (loss) from continuing operations 56,146 (32,371) 4,896 55,984 (611,077) (555,093) Earnings attributable to noncontrolling interests for continuing operations - (1,043) (18,872) (12,082) (40,341) (52,423) Income (loss) from continuing operations attributable to Kindred (a) $56,146 ($33,414) ($13,976) $43,902 ($651,418) ($607,516) Detail of charges: Severance, employee retention and restructuring costs $2,906 $10,874 $18,581 $2,125 $658 $2,783 Business interruption settlements (1,309) (1,309) Research and development ,227 7,227 Debt amendment ,103 1,103 Customer bankruptcy - - 1, Facility/branch closings RehabCare customer contract litigation ,864-12,864 Consulting fees related to LTAC criteria - - 2, Litigation contingency - 5,000 4,600 8,261 2,840 11,101 Restructuring charges ,288 28,860 32,148 Transaction costs 4,644 2,231 17,983 5,367 6,513 11,880 Impairment charges - 107,899-18, , ,239 7, ,004 45,481 49, , ,833 Core EBITDAR $582,173 $869,634 $684,215 $247,839 $734,804 $982,643 Rent $357,372 $428,979 $313,039 $97,823 $355,388 $453,211 Restructuring charges - rent ,363 60,252 Lease cancellation charges (included in rent expense) - 1, Core Rent 357, , ,792 96, , ,613 Core EBITDA $224,801 $442,346 $371,423 $150,905 $439,125 $590,030 (a) Amounts as originally reported on each of the Company's respective Form 10-K. 30

31 Reconciliation of Non-GAAP Measures (continued) ($ in thousands) Twelve Year ended months ended Core EBITDA by segment: 12/31/2010 9/30/2016 Hospital division $ 205,237 $ 251,694 Kindred at Home - 351,293 Kindred Rehabilitation Services 45, ,696 Nursing center division 105,051 40,288 Core EBITDA before Support Center 356, ,971 Support Center (131,304) (254,941) $ 224,801 (a) $ 590,030 (a) Adjusted EBITDA by segment (b): Hospital division $ 149,708 $ 168,185 Kindred at Home - 266,850 Kindred Rehabilitation Services 31, ,863 Nursing center division 43,485 3,132 $ 224,801 (a) $ 590,030 (a) (a) See slide 30 for a reconciliation of these amounts to GAAP income (loss) from continuing operations. (b) Support Center overhead allocated based upon percentage of total revenues by division (before intercompany eliminations). 31

32 Reconciliation of Non-GAAP Measures (continued) ($ in thousands) A reconciliation of combined Kindred Hospital Rehabilitation Services and Centerre revenues for each historical period follows: Year ended December 31, Nine months ended Twelve months ended Q /30/2016 9/30/2016 Kindred Hospital Rehabilitation Services: Acute rehabilitation units $122,381 $121,145 $120,784 $122,941 $125,972 $31,619 $97,021 $128,640 Inpatient rehabilitation facilities 28,714 57,204 65,484 75, ,492 80, , ,004 All other hospital-based rehabilitation contract services 78, , , , ,658 43, , , , , , , , , , ,186 Centerre consolidated IRFs (a) 75,563 90, , , Combined Hospital Rehabilitation Services Revenue $305,101 $441,722 $474,763 $549,453 $609,122 $155,579 $504,607 $660,186 Combined IRF revenue $104,277 $148,142 $188,150 $250,259 $305,492 $80,470 $268,534 $349,004 (a) For Centerre, only periods prior to acquisition are presented, or prior to January 1,

33 Reconciliation of Non-GAAP Measures (continued) ($ in thousands) A reconciliation of reported revenues to same-hospital revenues for the Hospital Division for each historical period follows: 2015 Quarters 2016 Quarters First Second Third Fourth First Second Third Reported revenues $640,483 $627,206 $579,497 $593,593 $643,299 $633,695 $575,323 Hospitals acquired and sold during 2016 (a) - (16,608) (14,679) (14,695) - (14,346) (13,731) Hospitals closed during 2016 (b) - - (7,376) (7,471) - - (5,447) Hospitals closed during 2015 (c) (5,508) (5,188) (2,160) (54) Same-hospital revenues $634,975 $605,410 $555,282 $571,925 $643,413 $619,427 $556,091 (a) Five hospitals acquired and three hospitals sold during the second quarter of (b) Three hospitals closed during the third quarter of (c) One hospital closed during the second quarter of 2015 and one hospital closed during the third quarter of

Genesis HealthCare. A Leading National Provider of Post-Acute Services. August 2015

Genesis HealthCare. A Leading National Provider of Post-Acute Services. August 2015 Genesis HealthCare A Leading National Provider of Post-Acute Services August 2015 Safe Harbor Statement Certain statements in this presentation regarding the expected benefits of the Skilled Healthcare

More information

A Leading National Provider of Post-Acute Services

A Leading National Provider of Post-Acute Services A Leading National Provider of Post-Acute Services November 2015 Safe Harbor Statement Certain statements in this presentation regarding the expected benefits of the Skilled Healthcare transaction, future

More information

Investor Presentation. March 2014

Investor Presentation. March 2014 Investor Presentation March 2014 Forward-Looking Statements This presentation includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section

More information

November Investor Presentation. ensigngroup.net

November Investor Presentation. ensigngroup.net November 2018 Investor Presentation Safe Harbor Statement Under the Private Securities Litigation Reform Act of 1995 Statements in this presentation concerning The Ensign Group s ( Ensign or the Company

More information

37 th Annual J.P. Morgan Healthcare Conference January 9, 2019

37 th Annual J.P. Morgan Healthcare Conference January 9, 2019 37 th Annual J.P. Morgan Healthcare Conference January 9, 2019 1 Disclaimer Statement This presentation contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933,

More information

A Leading National Provider of Post-Acute Services

A Leading National Provider of Post-Acute Services A Leading National Provider of Post-Acute Services February 2016 Safe Harbor Statement Certain statements in this presentation regarding the expected benefits of the Skilled Healthcare transaction, future

More information

A leading provider of post acute services

A leading provider of post acute services A leading provider of post acute services September 2017 2017 by Genesis Healthcare, Inc. All Rights Reserved. Safe Harbor Statement Certain statements in this presentation regarding the expected benefits

More information

A leading provider of post acute services

A leading provider of post acute services A leading provider of post acute services March 2018 2018 by Genesis Healthcare, Inc. All Rights Reserved. Safe Harbor Statement Certain statements in this presentation regarding the expected benefits

More information

Forward-Looking Statements

Forward-Looking Statements Forward-Looking Statements The information contained in this presentation includes certain estimates, projections and other forward-looking information that reflect HealthSouth s current outlook, views

More information

GENESIS HEALTHCARE REPORTS FOURTH QUARTER AND FISCAL YEAR END 2017 RESULTS

GENESIS HEALTHCARE REPORTS FOURTH QUARTER AND FISCAL YEAR END 2017 RESULTS Exhibit 99.1 FOR IMMEDIATE RELEASE Genesis HealthCare Contact: Investor Relations 610-925-2000 GENESIS HEALTHCARE REPORTS FOURTH QUARTER AND FISCAL YEAR END 2017 RESULTS KENNETT SQUARE, PA (March 16, 2018)

More information

Strong Third Quarter Performance and Growth With Pro Forma 1 Adjusted: o o

Strong Third Quarter Performance and Growth With Pro Forma 1 Adjusted: o o FOR IMMEDIATE RELEASE Genesis HealthCare Contact: Investor Relations 6109252000 GENESIS HEALTHCARE REPORTS THIRD QUARTER 2015 RESULTS Strong Third Quarter Performance and Growth With Pro Forma 1 Adjusted:

More information

GENESIS HEALTHCARE REPORTS STRONG SECOND QUARTER 2018 RESULTS

GENESIS HEALTHCARE REPORTS STRONG SECOND QUARTER 2018 RESULTS Exhibit 99.1 FOR IMMEDIATE RELEASE Genesis HealthCare Contact: Investor Relations 610-925-2000 GENESIS HEALTHCARE REPORTS STRONG SECOND QUARTER 2018 RESULTS KENNETT SQUARE, PA (August 7, 2018) Genesis

More information

Earnings Presentation 3rd Quarter, 2018

Earnings Presentation 3rd Quarter, 2018 Earnings Presentation 3rd Quarter, 2018 Forward-Looking Statements This presentation contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, Section

More information

FOR IMMEDIATE RELEASE. Genesis HealthCare Contact: Investor Relations GENESIS HEALTHCARE REPORTS FIRST QUARTER 2015 RESULTS

FOR IMMEDIATE RELEASE. Genesis HealthCare Contact: Investor Relations GENESIS HEALTHCARE REPORTS FIRST QUARTER 2015 RESULTS FOR IMMEDIATE RELEASE Genesis HealthCare Contact: Investor Relations 610-925-2000 GENESIS HEALTHCARE REPORTS FIRST QUARTER 2015 RESULTS Solid Quarter With Pro Forma 1 Adjusted: o EBITDAR of $185.4 Million

More information

Skilled Healthcare Group, Inc + Genesis HealthCare LLC

Skilled Healthcare Group, Inc + Genesis HealthCare LLC Skilled Healthcare Group, Inc + Genesis HealthCare LLC Creating a Leading National Provider of Post-Acute Services November 2014 Safe Harbor Statement Certain statements in this presentation regarding

More information

GENESIS HEALTHCARE ANNOUNCES PLANS TO STRENGTHEN CAPITAL STRUCTURE AND REPORTS THIRD QUARTER 2017 RESULTS

GENESIS HEALTHCARE ANNOUNCES PLANS TO STRENGTHEN CAPITAL STRUCTURE AND REPORTS THIRD QUARTER 2017 RESULTS FOR IMMEDIATE RELEASE Genesis HealthCare Contact: Investor Relations 610-925-2000 GENESIS HEALTHCARE ANNOUNCES PLANS TO STRENGTHEN CAPITAL STRUCTURE AND REPORTS THIRD QUARTER 2017 RESULTS KENNETT SQUARE,

More information

A leading provider of post acute services

A leading provider of post acute services A leading provider of post acute services May 2017 2017 by Genesis Healthcare, Inc. All Rights Reserved. Safe Harbor Statement Certain statements in this presentation regarding the expected benefits of

More information

A leading provider of post acute services

A leading provider of post acute services A leading provider of post acute services November 2018 2018 by Genesis Healthcare, Inc. All Rights Reserved. Safe Harbor Statement Certain statements in this presentation regarding the expected benefits

More information

INVESTING IN THE FUTURE of Healthcare

INVESTING IN THE FUTURE of Healthcare INVESTING IN THE FUTURE of Healthcare Jefferies 2015 Global Healthcare Conference June 1, 2015 1 SAFE HARBOR This presentation includes forward-looking statements within the meaning of securities laws

More information

2018 J.P. Morgan Healthcare Conference. Mark Tarr, President and Chief Executive Officer January 9, 2018

2018 J.P. Morgan Healthcare Conference. Mark Tarr, President and Chief Executive Officer January 9, 2018 2018 J.P. Morgan Healthcare Conference Mark Tarr, President and Chief Executive Officer January 9, 2018 Forward-Looking Statements The information contained in this presentation includes certain estimates,

More information

Investor Presentation February 22, 2018

Investor Presentation February 22, 2018 Investor Presentation February 22, 2018 Forward-Looking Statements Safe Harbor Certain statements in this Investor Presentation may constitute forward-looking statements within the meaning of the Private

More information

Nasdaq: DVCR. Investor Update. As of September 30, 2017

Nasdaq: DVCR. Investor Update. As of September 30, 2017 Investor Update As of September 30, 2017 Forward-Looking Statements Nasdaq: DVCR Forward-looking statements made in this presentation involve a number of risks and uncertainties, but not limited to: the

More information

GENESIS HEALTHCARE REPORTS FOURTH QUARTER AND FISCAL YEAR END 2015 RESULTS

GENESIS HEALTHCARE REPORTS FOURTH QUARTER AND FISCAL YEAR END 2015 RESULTS FOR IMMEDIATE RELEASE Genesis HealthCare Contact: Investor Relations 610-925-2000 GENESIS HEALTHCARE REPORTS FOURTH QUARTER AND FISCAL YEAR END 2015 RESULTS KENNETT SQUARE, PA (February 22, 2016) Genesis

More information

Tenet Reports Second Quarter 2010 Results

Tenet Reports Second Quarter 2010 Results åéïëêéäé~ëé Tenet Reports Second Quarter 2010 Results Diluted Earnings of $0.05 Per Share, Up from Loss of $0.03 Per Share Over Prior Year Period Net Income Attributable to Common Shareholders of $25 Million,

More information

Bank of America Leverage Finance Conference. November 29, 2016

Bank of America Leverage Finance Conference. November 29, 2016 Bank of America Leverage Finance Conference November 29, 2016 FORWARD-LOOKING STATEMENTS Certain statements in this presentation constitute forward-looking statements that is, statements that relate to

More information

Jefferies 2017 Health Care Conference

Jefferies 2017 Health Care Conference Jefferies 2017 Health Care Conference New York June 2017 Forward Looking Statements This presentation contains, and answers given to questions that may be asked today may constitute, forward-looking statements

More information

Almost Family Reports Second Quarter and Year to Date 2017 Results

Almost Family Reports Second Quarter and Year to Date 2017 Results Almost Family, Inc. Steve Guenthner (502) 891-1000 FOR IMMEDIATE RELEASE Almost Family Reports Second Quarter and Year to Date 2017 Results Louisville, KY, Almost Family, Inc. (NASDAQ: AFAM), a leading

More information

Earnings Presentation 4th Quarter, 2017

Earnings Presentation 4th Quarter, 2017 Earnings Presentation 4th Quarter, 2017 Forward-Looking Statements This presentation contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, Section

More information

GENESIS HEALTHCARE ANNOUNCES PRELIMINARY 2016 GROWTH OUTLOOK AND ADJUSTS 2015 GUIDANCE

GENESIS HEALTHCARE ANNOUNCES PRELIMINARY 2016 GROWTH OUTLOOK AND ADJUSTS 2015 GUIDANCE FOR IMMEDIATE RELEASE Genesis HealthCare Contact: Investor Relations 610-925-2000 GENESIS HEALTHCARE ANNOUNCES PRELIMINARY 2016 GROWTH OUTLOOK AND ADJUSTS 2015 GUIDANCE KENNETT SQUARE, PA (January 25,

More information

Tenet Reports Results for the Second Quarter Ended June 30, 2018

Tenet Reports Results for the Second Quarter Ended June 30, 2018 Tenet Reports Results for the Second Quarter Ended June 30, 2018 Tenet reported net income from continuing operations available to Tenet common shareholders of $24 million or $0.23 per diluted share in

More information

Discussion of Results (Percentage changes compare Q4 12 to Q4 11, unless otherwise noted.)

Discussion of Results (Percentage changes compare Q4 12 to Q4 11, unless otherwise noted.) Tenet Reports Fourth Quarter Adjusted EBITDA of $336 Million, an Increase of 16.7% 7.3% Growth in Net Operating Revenues 2.9% Increase in Adjusted Admissions 7.5% Growth in Surgeries DALLAS February 26,

More information

Earnings Presentation 2nd Quarter 2017

Earnings Presentation 2nd Quarter 2017 Earnings Presentation 2nd Quarter 2017 Forward-Looking Statements This presentation contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, Section

More information

Discussion of Results (Percentage changes compare Q3 12 to Q3 11, unless otherwise noted.)

Discussion of Results (Percentage changes compare Q3 12 to Q3 11, unless otherwise noted.) Tenet Reports Third Quarter Adjusted EBITDA Growth of 40% to $269 Million 5.8% Growth in Net Operating Revenues 1.4% Increase in Adjusted Admissions 6.3% Growth in Outpatient Surgeries 3.7% Increase in

More information

Tenet Reports Adjusted EBITDA of $529 Million for the Quarter Ended March 31, 2015

Tenet Reports Adjusted EBITDA of $529 Million for the Quarter Ended March 31, 2015 Tenet Reports Adjusted EBITDA of $529 Million for the Quarter Ended March 31, 2015 DALLAS May 4, 2015 Tenet Healthcare Corporation (NYSE:THC) reported Adjusted EBITDA of $529 million for the first quarter

More information

Tenet Reports $336 Million of Adjusted EBITDA for Second Quarter 16.7% Increase in Adjusted EBITDA 6.9

Tenet Reports $336 Million of Adjusted EBITDA for Second Quarter 16.7% Increase in Adjusted EBITDA 6.9 Tenet Reports $336 Million of Adjusted EBITDA for Second Quarter 16.7% Increase in Adjusted EBITDA 6.9% Increase in Net Operating Revenues Acquisition of Vanguard Health Systems Expected to Close by Year-End

More information

LHC Group and Almost Family: A Leading National Provider of In-Home Healthcare. November 16, 2017

LHC Group and Almost Family: A Leading National Provider of In-Home Healthcare. November 16, 2017 LHC Group and Almost Family: A Leading National Provider of In-Home Healthcare November 16, 2017 Forward-Looking Statements This presentation contains forward looking statements (as defined in the Securities

More information

Investor Presentation

Investor Presentation Investor Presentation J.P. Morgan 36 th Annual Healthcare Conference San Francisco, CA January 2018 Forward-Looking Statements This presentation contains forward-looking statements (as defined in the Securities

More information

Investor Presentation. May 2018

Investor Presentation. May 2018 Investor Presentation May 2018 Forward-Looking Statements This presentation contains forward-looking statements (as defined in the Securities Litigation Reform Act of 1995) regarding, among other things,

More information

Tenet Reports Results for the Third Quarter Ended September 30, 2018

Tenet Reports Results for the Third Quarter Ended September 30, 2018 Tenet Reports Results for the Third Quarter Ended September 30, 2018 Tenet reported a net loss from continuing operations attributable to Tenet common shareholders of $9 million or $0.09 per diluted share

More information

Bank of America Merrill Lynch 2018 Leveraged Finance Conference December 4, 2018

Bank of America Merrill Lynch 2018 Leveraged Finance Conference December 4, 2018 Bank of America Merrill Lynch 2018 Leveraged Finance Conference December 4, 2018 Forward-Looking Statements This presentation contains forward-looking statements within the meaning of Section 27A of the

More information

JP Morgan Healthcare Conference January 13, 2016

JP Morgan Healthcare Conference January 13, 2016 JP Morgan Healthcare Conference January 13, 2016 FORWARD-LOOKING STATEMENTS Certain statements and information in this presentation may be deemed to be forward-looking statements within the meaning of

More information

Raymond James 37 th Annual Institutional Investors Conference. March 8, 2016

Raymond James 37 th Annual Institutional Investors Conference. March 8, 2016 Raymond James 37 th Annual Institutional Investors Conference March 8, 2016 Forward-looking statements and Non-GAAP financial measures Forward-looking statements Certain statements included in this presentation,

More information

36 th Annual J.P. Morgan Healthcare Conference January 9, Bruce D. Broussard President & CEO

36 th Annual J.P. Morgan Healthcare Conference January 9, Bruce D. Broussard President & CEO 36 th Annual J.P. Morgan Healthcare Conference January 9, 2018 Bruce D. Broussard President & CEO 0 Cautionary statement This presentation includes forward-looking statements within the meaning of the

More information

36 th Annual J.P. Morgan Healthcare Conference. January 10, 2018

36 th Annual J.P. Morgan Healthcare Conference. January 10, 2018 36 th Annual J.P. Morgan Healthcare Conference January 10, 2018 Forward-Looking Statements and Non-GAAP Financial Measures This presentation includes information that may constitute forward-looking statements,

More information

Investor Presentation September DaVita Inc. All rights reserved.

Investor Presentation September DaVita Inc. All rights reserved. Investor Presentation September 2017 1 DaVita Inc. and its representatives may from time to time make written and oral forward looking statements within the meaning of the Private Securities Litigation

More information

Post-Acute and Long-Term Care Reform / Estimating the Federal Budgetary Effects of the AHCA/NCAL/Alliance Proposal

Post-Acute and Long-Term Care Reform / Estimating the Federal Budgetary Effects of the AHCA/NCAL/Alliance Proposal Post-Acute and Long-Term Care Reform / Estimating the Federal Budgetary Effects of the AHCA/NCAL/Alliance Proposal April 2009 Prepared for: The American Health Care Association National Center for Assisted

More information

Surgical Care Affiliates, Inc. 32 nd Annual J.P. Morgan Healthcare Conference. January 2014

Surgical Care Affiliates, Inc. 32 nd Annual J.P. Morgan Healthcare Conference. January 2014 Surgical Care Affiliates, Inc. 32 nd Annual J.P. Morgan Healthcare Conference January 2014 Disclaimer Certain statements herein are forward-looking statements made pursuant to the safe harbor provisions

More information

Healthcare Reform and Its Impact on the Care Delivery System

Healthcare Reform and Its Impact on the Care Delivery System Healthcare Reform and Its Impact on the Care Delivery System Agenda 1) The Era of Healthcare Reform 2) Healthcare Reform and Post-Acute Care 3) Succeeding in the Reform Era: Managing the Continuum of Health

More information

NAREIT Presentation. June 12-14, 2012

NAREIT Presentation. June 12-14, 2012 NAREIT Presentation June 12-14, 2012 Forward Looking Statements This document may contain forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995. These forwardlooking

More information

Results as of December 31, 2017

Results as of December 31, 2017 Results as of December 31, 2017 Safe Harbor and Regulation G Statement This presentation contains information about Chemed s EBITDA, Adjusted EBITDA, EBIT, Adjusted EBIT, Adjusted Net Income and Adjusted

More information

SUMMA HEALTH SYSTEM OBLIGATED GROUP CONTINUING DISCLOSURE FOR THE THREE MONTHS ENDED MARCH 31, 2012

SUMMA HEALTH SYSTEM OBLIGATED GROUP CONTINUING DISCLOSURE FOR THE THREE MONTHS ENDED MARCH 31, 2012 SUMMA HEALTH SYSTEM OBLIGATED GROUP CONTINUING DISCLOSURE FOR THE THREE MONTHS ENDED MARCH 31, 2012 MANAGEMENT S DISCUSSION AND ANALYSIS OF THE RESULTS OF OPERATIONS AND FINANCIAL POSITION SUMMA HEALTH

More information

MANAGEMENT S DISCUSSION OF FINANCIAL AND OPERATING PERFORMANCE

MANAGEMENT S DISCUSSION OF FINANCIAL AND OPERATING PERFORMANCE MANAGEMENT S DISCUSSION OF FINANCIAL AND OPERATING PERFORMANCE Utilization Trends The Corporation has experienced an increase in utilization from the end of 2015 through fiscal year 2017. Occupancy of

More information

McKESSON REPORTS FISCAL 2017 SECOND-QUARTER RESULTS AND REVISED FISCAL 2017 OUTLOOK

McKESSON REPORTS FISCAL 2017 SECOND-QUARTER RESULTS AND REVISED FISCAL 2017 OUTLOOK McKESSON REPORTS FISCAL 2017 SECOND-QUARTER RESULTS AND REVISED FISCAL 2017 OUTLOOK Revenues of $50.0 billion for the second quarter, up 2% year-over-year. Second-quarter GAAP earnings per diluted share

More information

INVESTOR UPDATE NOVEMBER 2017

INVESTOR UPDATE NOVEMBER 2017 INVESTOR UPDATE NOVEMBER 2017 FORWARD-LOOKING STATEMENTS AND NON-GAAP FINANCIAL INFORMATION Forward-Looking Statements Certain statements and information in this communication may be deemed to be forward-looking

More information

Baird 2018 Global Healthcare Conference. September 5, 2018

Baird 2018 Global Healthcare Conference. September 5, 2018 Baird 2018 Global Healthcare Conference September 5, 2018 Forward-Looking Statements and Non-GAAP Financial Measures This presentation includes information that may constitute forward-looking statements,

More information

Universal Health Services, Inc. Reports 2018 Third Quarter Financial Results And Narrows 2018 Full Year Earnings Guidance Range

Universal Health Services, Inc. Reports 2018 Third Quarter Financial Results And Narrows 2018 Full Year Earnings Guidance Range Reports 2018 Third Quarter Financial Results And Narrows 2018 Full Year Earnings Guidance Range October 25, 2018 Webcast - Live Q3 2018 Universal Health Services Earnings Conference Call 10/26/18 at 9:00

More information

McKESSON REPORTS FISCAL 2017 FIRST-QUARTER RESULTS

McKESSON REPORTS FISCAL 2017 FIRST-QUARTER RESULTS McKESSON REPORTS FISCAL 2017 FIRST-QUARTER RESULTS Revenues of $49.7 billion for the first quarter, up 5% year-over-year. First-quarter GAAP earnings per diluted share from continuing operations of $2.88,

More information

news FOR IMMEDIATE RELEASE

news FOR IMMEDIATE RELEASE news FOR IMMEDIATE RELEASE INVESTOR CONTACT: MEDIA CONTACT: Mark Kimbrough Ed Fishbough 615-344-2688 615-344-2810 HCA Reports Third Quarter 2018 Results Nashville, Tenn., October 30, 2018 HCA Healthcare,

More information

Cowen and Company 38 th Annual Health Care Conference. March 13, 2018

Cowen and Company 38 th Annual Health Care Conference. March 13, 2018 Cowen and Company 38 th Annual Health Care Conference March 13, 2018 Forward-Looking Statements and Non-GAAP Financial Measures This presentation includes information that may constitute forward-looking

More information

DaVita HealthCare Partners. J.P. Morgan Healthcare Conference January 8, 2013

DaVita HealthCare Partners. J.P. Morgan Healthcare Conference January 8, 2013 DaVita HealthCare Partners J.P. Morgan Healthcare Conference January 8, 2013 Certain statements in today s presentation contain forward-looking statements within the meaning of the federal securities laws.

More information

Select Medical Holdings Corporation Announces Results For Its First Quarter Ended March 31, 2018

Select Medical Holdings Corporation Announces Results For Its First Quarter Ended March 31, 2018 FOR IMMEDIATE RELEASE 4714 Gettysburg Road Mechanicsburg, PA 17055 NYSE Symbol: SEM Select Medical Holdings Corporation Announces Results For Its First Quarter Ended March 31, 2018 MECHANICSBURG, PENNSYLVANIA

More information

Coverage Expansion [Sections 310, 323, 324, 341, 342, 343, 344, and 1701]

Coverage Expansion [Sections 310, 323, 324, 341, 342, 343, 344, and 1701] Summary of the U.S. House of Representatives Health Reform Bill October 2009 The following summarizes the major hospital and health system provisions included in the U.S. House of Representatives health

More information

Baird 2012 Healthcare Conference New York City September 6, Jay Grinney, President and Chief Executive Officer

Baird 2012 Healthcare Conference New York City September 6, Jay Grinney, President and Chief Executive Officer Baird 2012 Healthcare Conference New York City September 6, 2012 Jay Grinney, President and Chief Executive Officer Forward-Looking Statements The information contained in this presentation includes certain

More information

news FOR IMMEDIATE RELEASE

news FOR IMMEDIATE RELEASE news FOR IMMEDIATE RELEASE INVESTOR CONTACT: MEDIA CONTACT: Mark Kimbrough Ed Fishbough 615-344-2688 615-344-2810 HCA Reports First Quarter 2018 Results Nashville, Tenn., May 1, 2018 HCA Healthcare, Inc.

More information

VENTAS REPORTS RECORD 2014 FOURTH QUARTER AND FULL YEAR RESULTS

VENTAS REPORTS RECORD 2014 FOURTH QUARTER AND FULL YEAR RESULTS Ventas, Inc. 353 North Clark Street, Suite 3300 Chicago, Illinois 60654 (877) 4-VENTAS www.ventasreit.com Contact: Lori B. Wittman (877) 4-VENTAS VENTAS REPORTS RECORD 2014 FOURTH QUARTER AND FULL YEAR

More information

McKESSON REPORTS FISCAL 2019 SECOND-QUARTER RESULTS

McKESSON REPORTS FISCAL 2019 SECOND-QUARTER RESULTS McKESSON REPORTS FISCAL 2019 SECOND-QUARTER RESULTS Revenues of $53.1 billion for the second quarter, up 2% year over year. Second-quarter GAAP earnings per diluted share from continuing operations of

More information

Relationship driven. Investor focused. JMP Securities December 11-13, 2017

Relationship driven. Investor focused. JMP Securities December 11-13, 2017 Relationship driven. Investor focused. JMP Securities December 11-13, 2017 Sabra 3.0 Update TRANSFORMATION OVERVIEW Sabra 3.0 Sabra 1.0 Sabra spins off from Sun Healthcare in November 2010 and begins publicly

More information

Annual Shareholders Meeting. May 21, 2018

Annual Shareholders Meeting. May 21, 2018 Annual Shareholders Meeting May 21, 2018 Safe Harbor and Regulation G Statement This presentation contains information about Chemed s EBITDA, Adjusted EBITDA, EBIT, Adjusted EBIT, Adjusted Net Income and

More information

Quarterly Results Presentation

Quarterly Results Presentation Quarterly Results Presentation Third Quarter of 2016 October 31, 2016 FORWARD-LOOKING STATEMENTS Certain statements in this presentation constitute forward-looking statements that is, statements that relate

More information

35th Annual J.P. Morgan Healthcare Conference. January 12, 2017

35th Annual J.P. Morgan Healthcare Conference. January 12, 2017 35th Annual J.P. Morgan Healthcare Conference January 12, 2017 Safe Harbor Statement and Non-GAAP Financial Measures This presentation contains forward-looking statements, including statements regarding

More information

Investor Presentation. September, 2017

Investor Presentation. September, 2017 Investor Presentation September, 2017 Safe Harbor SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS AND INFORMATION This presentation contains statements about future events and expectations that constitute

More information

The Ensign Group Reports Quarterly Adjusted Earnings of $0.44 per Share

The Ensign Group Reports Quarterly Adjusted Earnings of $0.44 per Share November 5, 2014 The Ensign Group Reports Quarterly Adjusted Earnings of $0.44 per Share Conference Call and Webcast Scheduled for November 6, 2014 at 10:00 am PT MISSION VIEJO, Calif., Nov. 5, 2014 (GLOBE

More information

Fourth Quarter and Full Year 2017 Results Conference Call. March 9, 2018

Fourth Quarter and Full Year 2017 Results Conference Call. March 9, 2018 Fourth Quarter and Full Year 2017 Results Conference Call March 9, 2018 Forward-Looking Statements and Non-GAAP Financial Measures This presentation includes information that may constitute forward-looking

More information

Bank of America Merrill Lynch 2017 Leveraged Finance Conference

Bank of America Merrill Lynch 2017 Leveraged Finance Conference Bank of America Merrill Lynch 2017 Leveraged Finance Conference Keith Pitts, Vice Chairman FORWARD-LOOKING STATEMENTS This presentation includes forward-looking statements. These statements relate to future

More information

Cantor Fitzgerald 2017 Global Healthcare Conference. September 26, 2017

Cantor Fitzgerald 2017 Global Healthcare Conference. September 26, 2017 Cantor Fitzgerald 2017 Global Healthcare Conference September 26, 2017 Forward-Looking Statements and Non-GAAP Financial Measures This presentation contains forward-looking statements, including statements

More information

Powering healthcare provider success

Powering healthcare provider success Powering healthcare provider success Now and in the future 38 th Annual William Blair Growth Stock Conference June 12, 2018 TRANSFORMING HEALTHCARE TOGETHER Premier Inc. 2018 1 Forward-looking statements

More information

Annual Report For the Period Ending 6/30/12

Annual Report For the Period Ending 6/30/12 This Document is Dated as of November 1, 2012. SPECIAL NOTE CONCERNING FORWARD-LOOKING STATEMENTS: Certain of the discussions included in the Management Discussion and Analysis section of the following

More information

Select Medical Holdings Corporation Announces Results For Its Second Quarter Ended June 30, 2018

Select Medical Holdings Corporation Announces Results For Its Second Quarter Ended June 30, 2018 . FOR IMMEDIATE RELEASE 4714 Gettysburg Road Mechanicsburg, PA 17055 NYSE Symbol: SEM Select Medical Holdings Corporation Announces Results For Its Second Quarter Ended June 30, 2018 MECHANICSBURG, PENNSYLVANIA

More information

Powering healthcare provider success

Powering healthcare provider success Powering healthcare provider success Now and in the future Investor Information September 2018 TRANSFORMING HEALTHCARE TOGETHER Premier Inc. 2018 1 Forward-looking statements and non-gaap financial measures

More information

Third Quarter 2018 Results Conference Call. November 7, 2018

Third Quarter 2018 Results Conference Call. November 7, 2018 Third Quarter 2018 Results Conference Call November 7, 2018 Forward-Looking Statements and Non-GAAP Financial Measures This presentation includes information that may constitute forward-looking statements,

More information

Universal Health Services, Inc. Reports 2018 First Quarter Financial Results

Universal Health Services, Inc. Reports 2018 First Quarter Financial Results Reports 2018 First Quarter Financial Results April 25, 2018 Webcast - Live Q1 2018 Universal Health Services Earnings Conference Call 4/26/18 at 9:00 a.m. ET Consolidated Results of Operations, As Reported

More information

Jefferies Healthcare Conference

Jefferies Healthcare Conference Jefferies Healthcare Conference June 7, 2017 Disclaimer Certain statements in this presentation and other oral or written statements made by the Company from time to time are may constitute forward-looking

More information

Lehigh Valley Health Network

Lehigh Valley Health Network Lehigh Valley Health Network Journey to Accountable Care November 19, 2014 Powered by Populytics Lehigh Valley Health Network Fast Facts In Allentown/Bethlehem area, north of Philadelphia Recognized by

More information

The Ensign Group Reports Record Quarter; Q Earnings of $0.60 per Share

The Ensign Group Reports Record Quarter; Q Earnings of $0.60 per Share The Ensign Group Reports Record Quarter; Q2 2011 Earnings of $0.60 per Share Conference Call and Webcast Scheduled for August 4, 2011 at 10:30 am PT MISSION VIEJO, Calif., Aug. 3, 2011 /PRNewswire/ --

More information

CENTEGRA HEALTH SYSTEM AND AFFILIATES CONSOLIDATING STATEMENT OF REVENUE AND EXPENSES FOR THE TWELVE MONTHS ENDED JUNE 30, 2017 Unaudited

CENTEGRA HEALTH SYSTEM AND AFFILIATES CONSOLIDATING STATEMENT OF REVENUE AND EXPENSES FOR THE TWELVE MONTHS ENDED JUNE 30, 2017 Unaudited CONSOLIDATING STATEMENT OF REVENUE AND EXPENSES FOR THE TWELVE MONTHS ENDED JUNE 30, 2017 HOSPITAL THE CENTEGRA HEALTH BRIDGE CLINICAL CHWN GROUP FOUNDATION NIMED COMBINED LAB CMS CPC COMBINED CIS ELIMINATIONS

More information

Almost Family Reports Second Quarter 2016 Results

Almost Family Reports Second Quarter 2016 Results Exhibit 99.1 Almost Family, Inc. Steve Guenthner (502) 891-1000 FOR IMMEDIATE RELEASE Almost Family Reports Second Quarter 2016 Results Louisville, KY, Almost Family, Inc. (Nasdaq: AFAM), a leading regional

More information

Jefferies 2017 Global Healthcare Conference Thursday, June 8, 2017

Jefferies 2017 Global Healthcare Conference Thursday, June 8, 2017 Jefferies 2017 Global Healthcare Conference Thursday, June 8, 2017 Forward-Looking Statements This presentation contains forward-looking statements within the meaning of federal securities laws that involve

More information

J.P. Morgan Healthcare Conference January DaVita Inc. All rights reserved.

J.P. Morgan Healthcare Conference January DaVita Inc. All rights reserved. J.P. Morgan Healthcare Conference January 2018 1 DaVita Inc. and its representatives may from time to time make written and oral forward-looking statements within the meaning of the Private Securities

More information

Wells Fargo Securities Healthcare Conference September 7, 2017

Wells Fargo Securities Healthcare Conference September 7, 2017 Wells Fargo Securities Healthcare Conference September 7, 2017 Forward Looking Statements & Non-GAAP Financial Measures Except as otherwise indicated or unless the context otherwise requires, all references

More information

The Driving Forces of Operator Performance: Past, Present & Future

The Driving Forces of Operator Performance: Past, Present & Future The Driving Forces of Operator Performance: Past, Present & Future - MAY 2018 - Forward-looking Statements and Non- GAAP Information This presentation may include projections and other forward-looking

More information

HEALTH POLICY & EDUCATION SERIES

HEALTH POLICY & EDUCATION SERIES HEALTH POLICY & PAYMENT EDUCATION SERIES Medicare s Bundled Payment Initiatives The information in this document is based off of policy information available as of August 2016. Updated information may

More information

Investor Presentation. February 2012

Investor Presentation. February 2012 Investor Presentation February 2012 Safe Harbor Some of the statements made in this presentation constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act

More information

Select Medical Holdings Corporation Announces Results for First Quarter Ended March 31, 2017

Select Medical Holdings Corporation Announces Results for First Quarter Ended March 31, 2017 R E L E A S E FOR IMMEDIATE RELEASE 4714 Gettysburg Road Mechanicsburg, PA 17055 NYSE Symbol: SEM Select Medical Holdings Corporation Announces Results for First Quarter Ended March 31, 2017 MECHANICSBURG,

More information

QUARTERLY REPORT ORLANDO HEALTH, INC. Quarter Ended December 31, 2018

QUARTERLY REPORT ORLANDO HEALTH, INC. Quarter Ended December 31, 2018 QUARTERLY REPORT ORLANDO HEALTH, INC. Quarter Ended Filed by: Address: 1414 Kuhl Avenue Orlando, FL 32806 Contact: John Miller, Vice President, Finance Contents Interim Consolidated Financial Statements

More information

Annual Report For the Fiscal Year Ending 6/30/15

Annual Report For the Fiscal Year Ending 6/30/15 This Document is Dated as of October 1, 2015. SPECIAL NOTE CONCERNING FORWARD-LOOKING STATEMENTS: Certain of the discussions included in the Management Discussion and Analysis section of the following

More information

FUNDS FLOW METHODOLOGY FOR RISK-BASED CONTRACTS

FUNDS FLOW METHODOLOGY FOR RISK-BASED CONTRACTS CENTER FOR INDUSTRY TRANSFORMATION MAY 2015 FUNDS FLOW METHODOLOGY FOR RISK-BASED CONTRACTS Authors Amy Bibby Partner, DHG Healthcare amy.bibby@dhgllp.com Matthew Fadel Manager, DHG Healthcare matt.fadel@dhgllp.com

More information

2017 WELLS FARGO HEALTHCARE CONFERENCE

2017 WELLS FARGO HEALTHCARE CONFERENCE 2017 WELLS FARGO HEALTHCARE CONFERENCE September 7, 2017 TRANSFORMING HEALTHCARE TOGETHER UNIQUELY POSITIONED FOR THE FUTURE 2017 1 Craig McKasson Chief Financial Officer Premier Inc. TRANSFORMING HEALTHCARE

More information

Allscripts Healthcare Solutions

Allscripts Healthcare Solutions Allscripts Healthcare Solutions J A N U A R Y 2 0 1 9 J.P. Morgan Healthcare Conference Disclaimer This presentation contains forward-looking statements within the meaning of the Private Securities Litigation

More information

McKESSON REPORTS FISCAL 2015 THIRD-QUARTER RESULTS

McKESSON REPORTS FISCAL 2015 THIRD-QUARTER RESULTS McKESSON REPORTS FISCAL 2015 THIRD-QUARTER RESULTS Revenues of $47 billion for the third quarter, up 37%. Third-quarter GAAP earnings per diluted share from continuing operations of $2.01, up 187%. Third-quarter

More information

Cowen and Company 37 th Annual Health Care Conference. March 6, 2017

Cowen and Company 37 th Annual Health Care Conference. March 6, 2017 Cowen and Company 37 th Annual Health Care Conference March 6, 2017 Safe Harbor Statement and Non-GAAP Financial Measures This presentation contains forward-looking statements, including statements regarding

More information